APP Causes Hyperexcitability in Fragile X Mice

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2016 Dec 27

PMID 28018172

Citations 17

Authors

Cara J Westmark

Shih-Chieh Chuang

Seth A Hays

Mikolaj J Filon

Brian C Ray

Pamela R Westmark

Jay R Gibson

Kimberly M Huber

Robert K S Wong

Affiliations

Soon will be listed here.

Abstract

Amyloid-beta protein precursor (APP) and metabolite levels are altered in fragile X syndrome (FXS) patients and in the mouse model of the disorder, mice. Normalization of APP levels in mice ( / mice) rescues many disease phenotypes. Thus, APP is a potential biomarker as well as therapeutic target for FXS. Hyperexcitability is a key phenotype of FXS. Herein, we determine the effects of APP levels on hyperexcitability in brain slices. / slices exhibit complete rescue of UP states in a neocortical hyperexcitability model and reduced duration of ictal discharges in a CA3 hippocampal model. These data demonstrate that APP plays a pivotal role in maintaining an appropriate balance of excitation and inhibition (E/I) in neural circuits. A model is proposed whereby APP acts as a rheostat in a molecular circuit that modulates hyperexcitability through mGluR and FMRP. Both over- and under-expression of APP in the context of the increases seizure propensity suggesting that an APP rheostat maintains appropriate E/I levels but is overloaded by mGluR-mediated excitation in the absence of FMRP. These findings are discussed in relation to novel treatment approaches to restore APP homeostasis in FXS.

Citing Articles

Fragile X mental retardation protein coordinates neuron-to-glia communication for clearance of developmentally transient brain neurons.

Song C, Broadie K Proc Natl Acad Sci U S A. 2023; 120(12):e2216887120.

PMID: 36920921 PMC: 10041173. DOI: 10.1073/pnas.2216887120.

Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals.

Cencelli G, Pacini L, De Luca A, Messia I, Gentile A, Kang Y Cells. 2023; 12(5).

PMID: 36899894 PMC: 10000963. DOI: 10.3390/cells12050758.

Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models.

Susco S, Ghosh S, Mazzucato P, Angelini G, Beccard A, Barrera V Cell Rep. 2022; 40(10):111312.

PMID: 36070702 PMC: 9465809. DOI: 10.1016/j.celrep.2022.111312.

Amyloid beta induces Fmr1-dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2.

Lizarazo S, Yook Y, Tsai N J Cell Physiol. 2022; 237(7):2929-2942.

PMID: 35434801 PMC: 9283232. DOI: 10.1002/jcp.30754.

MDGA1 negatively regulates amyloid precursor protein-mediated synapse inhibition in the hippocampus.

Kim J, Kim S, Kim H, Hwang I, Bae S, Karki S Proc Natl Acad Sci U S A. 2022; 119(4).

PMID: 35074912 PMC: 8795569. DOI: 10.1073/pnas.2115326119.

References

Zhong J, Chuang S, Bianchi R, Zhao W, Lee H, Fenton A . BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J Neurosci. 2009; 29(32):9977-86. PMC: 2866649. DOI: 10.1523/JNEUROSCI.3893-08.2009. View

Young K, Pasternak S, Rylett R . Oligomeric aggregates of amyloid beta peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the alpha7 nicotinic receptor. Neurochem Int. 2009; 55(8):796-801. DOI: 10.1016/j.neuint.2009.08.002. View

Sun Q, Zhang Z, Jiao Y, Zhang C, Szabo G, Erdelyi F . Differential metabotropic glutamate receptor expression and modulation in two neocortical inhibitory networks. J Neurophysiol. 2009; 101(5):2679-92. PMC: 2681425. DOI: 10.1152/jn.90566.2008. View

Westmark C, Sokol D, Maloney B, Lahiri D . Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Mol Psychiatry. 2016; 21(10):1333-41. PMC: 5580495. DOI: 10.1038/mp.2016.134. View

Kobayashi D, Zeller M, Cole T, Buttini M, McConlogue L, Sinha S . BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease. Neurobiol Aging. 2007; 29(6):861-73. DOI: 10.1016/j.neurobiolaging.2007.01.002. View

Jin P, Warren S . Understanding the molecular basis of fragile X syndrome. Hum Mol Genet. 2000; 9(6):901-8. DOI: 10.1093/hmg/9.6.901. View

Pasciuto E, Ahmed T, Wahle T, Gardoni F, DAndrea L, Pacini L . Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome. Neuron. 2015; 87(2):382-98. DOI: 10.1016/j.neuron.2015.06.032. View

Wong R, Chuang S, Bianchi R . Plasticity mechanisms underlying mGluR-induced epileptogenesis. Adv Exp Med Biol. 2004; 548:69-75. DOI: 10.1007/978-1-4757-6376-8_5. View

Merlin L . Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol. 2002; 87(1):621-5. DOI: 10.1152/jn.00579.2001. View

10.

Minkeviciene R, Rheims S, Dobszay M, Zilberter M, Hartikainen J, Fulop L . Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci. 2009; 29(11):3453-62. PMC: 6665248. DOI: 10.1523/JNEUROSCI.5215-08.2009. View

11.

Michalon A, Bruns A, Risterucci C, Honer M, Ballard T, Ozmen L . Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Biol Psychiatry. 2013; 75(3):189-97. DOI: 10.1016/j.biopsych.2013.05.038. View

12.

Westmark C, Malter J . The regulation of AβPP expression by RNA-binding proteins. Ageing Res Rev. 2012; 11(4):450-9. PMC: 3402637. DOI: 10.1016/j.arr.2012.03.005. View

13.

Palop J, Chin J, Roberson E, Wang J, Thwin M, Bien-Ly N . Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007; 55(5):697-711. PMC: 8055171. DOI: 10.1016/j.neuron.2007.07.025. View

14.

Mucke L, Masliah E, Yu G, Mallory M, Rockenstein E, Tatsuno G . High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000; 20(11):4050-8. PMC: 6772621. View

15.

Steinbach J, Muller U, Leist M, Li Z, Nicotera P, Aguzzi A . Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ. 1999; 5(10):858-66. DOI: 10.1038/sj.cdd.4400391. View

16.

Chen L, Toth M . Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 2001; 103(4):1043-50. DOI: 10.1016/s0306-4522(01)00036-7. View

17.

Westmark C . What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders. Mol Psychiatry. 2012; 18(4):425-34. DOI: 10.1038/mp.2012.122. View

18.

Michalon A, Sidorov M, Ballard T, Ozmen L, Spooren W, Wettstein J . Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron. 2012; 74(1):49-56. PMC: 8822597. DOI: 10.1016/j.neuron.2012.03.009. View

19.

Parisiadou L, Bethani I, Michaki V, Krousti K, Rapti G, Efthimiopoulos S . Homer2 and Homer3 interact with amyloid precursor protein and inhibit Abeta production. Neurobiol Dis. 2008; 30(3):353-364. DOI: 10.1016/j.nbd.2008.02.004. View

20.

Bailey J, Maloney B, Ge Y, Lahiri D . Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis. Gene. 2011; 488(1-2):13-22. PMC: 3372404. DOI: 10.1016/j.gene.2011.06.017. View